Skip to content

Clinical trials

Phase 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myelogenous, Chronic, BCR-ABL Positive Phase: Phase 1 Country / region: Australia Clear all

6 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20142
20221
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bristol-Myers Squibb1
Children's Oncology Group1
Eilean Therapeutics AU Pty Ltd1
Enliven Therapeutics1
National Institutes of Health Clinical Center (CC)1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myelogenous, Chronic, BCR-ABL Positive6
Leukemia2
Precursor Cell Lymphoblastic Leukemia-Lymphoma2
Blast Crisis1
Leukemia, Biphenotypic, Acute1
Leukemia, Myeloid, Chronic-Phase1
Leukemia, Myelomonocytic, Juvenile1
Polycythemia1
Primary Myelofibrosis1
Recurrence1

Trials

Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.